Stay updated on RC48-ADC in Low HER2 Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.

Latest updates to the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAdded Beijing Municipality as a study location under Locations. Removed the HHS Vulnerability Disclosure and the Beijing Municipality Locations entry; page revision updated to v3.3.3.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedSite revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe funding notice near the top of the page has been removed, eliminating the disclosure about potential delays in updates due to funding gaps. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check62 days agoChange DetectedNo additions or deletions were detected in the Study Details page. The content appears consistent with the previous version, including the study design, eligibility criteria, outcomes, and contact information.SummaryDifference0.3%

- Check83 days agoChange DetectedOverall, the page updates to announce a funding-related operating status and open NIH Clinical Center status, and bumps from v3.1.0 to v3.2.0.SummaryDifference3%

- Check91 days agoChange DetectedPage now indicates Revision: v3.1.0 and adds contact details (phone and email); previously it showed Revision: v3.0.2. No other core content changes detected.SummaryDifference0.1%

Stay in the know with updates to RC48-ADC in Low HER2 Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in Low HER2 Breast Cancer Clinical Trial page.